Mistabron Respirator Solution 3 ml

Mistabron Respirator Solution 3 ml belongs to a class of medication known as 'cytoprotectant' primarily used to prevent Hemorrhagic cystitis (a condition that causes bleeding in the urine due to the effect of anticancer agents (Ifosfamide). Our body breaks down the anticancer agent (Ifosfamide) to form a chemical (acrolein) that can harm and irritate the bladder. Mistabron Respirator Solution 3 ml reduces the risk of inflammation and bleeding in the bladder due to other anti-cancer medications. 

Mistabron Respirator Solution 3 ml contains 'Mesna', a chemo-protectant medicine. It works by altering the breakdown of anti-cancer agents (Ifosfamide) found in urine, making it less toxic. In addition, it binds to other urotoxic metabolites and inhibits their effects on the bladder.

Mistabron Respirator Solution 3 ml should be used as advised by your physician. Avoid using more than the recommended dose. The dose of medicine will be advised by your doctor based on your health condition. In some cases, this medicine may cause certain side effects such as nausea, vomiting, headache, flushing (sense of warmth in the face, ears, neck, and trunk), lethargy, rash, diarrhea, light-headedness, abdominal pain, flu-like symptoms and fever. Most of these side effects of Mistabron Respirator Solution 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Mistabron Respirator Solution 3 ml is not recommended if you are allergic to it or any of its ingredients. Women of childbearing age should use an effective birth control method to prevent getting pregnant. While utilising Mistabron Respirator Solution 3 ml to track your CBC, your doctor could advise routine urine and blood tests (blood cell count). Because of various underlying clinical disorders, including thrombocytopenia, Mistabron Respirator Solution 3 ml is contraindicated for usage in hematuria. While using Mistabron Respirator Solution 3 ml, it is advisable to consume at least 1-2 litres of liquids every day. Due to significant adverse effects, this medication should not be used in pregnant or nursing women; thus, consult your doctor before beginning treatment with Mistabron Respirator Solution 3 ml.

Mistabron Respirator Solution 3 ml is a member of the 'chemoprotectant' class of drugs, which are principally used to stop urine bleeding caused by the anticancer drug ifosfamide (ifosfamide-induced hemorrhagic cystitis). Additionally, it lessens the chance that anti-cancer medications would induce bladder irritation and bleeding. It includes Mesna, which detoxifies the urotoxic ifosfamide (anti-cancer medication) metabolites by chemically interacting with them. Additionally, it binds to other urotoxic metabolites and prevents their bladder-damaging effects.

• Nausea
• Headache
• Flushing (sense of warmth in the face, ears, neck and trunk)
• Lethargy
• Rash
• Diarrhea
• Lightheadedness
• Abdominal pain
• Flu-like symptoms
• Fever

Do not use Mistabron Respirator Solution 3 ml if you are allergic to it or any of its ingredients. Mistabron Respirator Solution 3 ml should be used under the supervision of a doctor only. An effective birth control method should be used to avoid pregnancy in women of childbearing age. Maintain a 6-month gap between your last dose of name and your next pregnancy. Regular urine and blood test should be done while using this medicine to monitor your CBC (blood cell count). It is not indicated for use in hematuria due to other underlying pathological conditions like thrombocytopenia. It is important to drink at least 1 litre of fluid daily while using Mistabron Respirator Solution 3 ml. This medicine is known to cause blurry vision and dizziness, so do not drive or operate machinery.

• ANISINDIONE
• DICUMAROL
• WARFARIN

• Regular blood and urine test are required while using Mistabron Respirator Solution 3 ml.
• Mistabron Respirator Solution 3 ml may interfere with enzymatic creatinine phosphokinase (CPK) activity tests that use a thiol compound (N-acetylcysteine) for CPK reactivation. This may result in a falsely low CPK level. Inform your doctor about the use of Mistabron Respirator Solution 3 ml.
• Mistabron Respirator Solution 3 ml may interfere with a certain laboratory test (for urinary ketones), possibly causing false test results. Hence inform your doctor or laboratory personnel about the use of this medicine.

• Empty your bladder frequently in the first 24 hours of chemotherapy (cancer treatment). If any pain occurs during urination, let your doctor know it.
• Nausea can occur as a side effect of chemotherapy. Eat small and frequent meals to avoid it, or you can take any anti-nausea medicine.
• Sleep at least 8 hours a day and take plenty of rest.
• Maintain good nutrition. Eat home-cooked and freshly prepared food. Avoid junk, oily and spicy food.